RenSuper® Biologics: Empowering Next-Gen Dual-Payload ADCs with AI-Driven Precision & Scalability
- Leveraging RenLite® common light chain to eliminate mismatching, ensuring high homogeneity and "antibody-like" stability for complex dual-payload formats
- Combining two distinct, complementary MoAs on a single molecule to tackle tumour heterogeneity and bypass resistance.
- The RenSuper Workstation AI Platform scans 200+ TAA targets and hundreds of thousands of ready-to-go antibodies to match the ideal lead with optimal internalisation in record time